BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6967240)

  • 1. [Delayed hypersensitivity as a result of successful chemotherapy of neoplasms].
    Jedrzejczak WW
    Wiad Lek; 1980 Apr; 33(7):547-53. PubMed ID: 6967240
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of proteolysis on the human immune mechanism in cancer. A preliminary communication.
    Thornes RD; Smyth H; Browne O; O'Gorman M; Reen DJ; Farrell D; Holland PD
    J Med; 1974; 5(1):92-7. PubMed ID: 4275505
    [No Abstract]   [Full Text] [Related]  

  • 3. T-cell involvement in delayed-type hypersensitivity reactions to infliximab.
    Torres MJ; Chaves P; Doña I; Blanca-López N; Canto G; Mayorga C; Blanca M
    J Allergy Clin Immunol; 2011 Dec; 128(6):1365-1367.e1. PubMed ID: 21839501
    [No Abstract]   [Full Text] [Related]  

  • 4. [Various aspects of immunological response in patients with neoplasms].
    Sułowicz W
    Wiad Lek; 1982 Oct; 35(17):1077-81. PubMed ID: 6758359
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of cytostatic chemotherapy on delayed hypersensitivity reaction].
    Schneider M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):877-80. PubMed ID: 5709511
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic effects of estramustine phosphate.
    Kalland T; Haukaas SA
    Urology; 1984 Jun; 23(6 Suppl):39-45. PubMed ID: 6375078
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody carriers of drugs and toxins in tumor therapy.
    Immunol Rev; 1982; 62():1-216. PubMed ID: 7076274
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotoxic effects during acute ethylene glycol poisoning.
    Zabrodskii PF; Germanchuk VG
    Bull Exp Biol Med; 2000 Oct; 130(10):967-8. PubMed ID: 11177295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of postoperative adjuvant chemotherapy on the immune system in 100 cancer patients.
    Israel L; Samak R; Grefft-Alami A; Edelstein R
    Prog Clin Biol Res; 1983; 132E():35-44. PubMed ID: 6647476
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro tests in drug hypersensitivity diagnosis.
    Lochmatter P; Zawodniak A; Pichler WJ
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):537-54. PubMed ID: 19563996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams.
    Rodriguez-Pena R; Lopez S; Mayorga C; Antunez C; Fernandez TD; Torres MJ; Blanca M
    J Allergy Clin Immunol; 2006 Oct; 118(4):949-56. PubMed ID: 17030251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
    Pagani M; Bonadonna P; Senna GE; Antico A
    Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity during monochemotherapy with mitoxantrone: preliminary results.
    Cartei G; Contessi E; Comelli M; Turrin D; Toso C; Sibau A; Mian S; Bramezza M
    J Chemother; 1989 Jul; 1(4 Suppl):1309-10. PubMed ID: 16312879
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of cancer chemotherapy drugs: an alternative hypothesis based on inhibition of immunologic function.
    Sadoff L
    Cancer Chemother Rep; 1972 Oct; 56(5):559-62. PubMed ID: 4652586
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].
    Marconi P; Bistoni F
    Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083
    [No Abstract]   [Full Text] [Related]  

  • 19. T-cell-specific response to silicone gel.
    Smalley DL; Shanklin DR
    Plast Reconstr Surg; 1996 Oct; 98(5):915-6. PubMed ID: 8823055
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotoxins--theoretical and practical aspects.
    Hofstaetter T; Gronski P; Seiler FR
    Behring Inst Mitt; 1984 May; (74):113-21. PubMed ID: 6383320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.